Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mujie Ye

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
BMC Gastroenterology|June 11, 2026
Machine learning models to predict the recurrence of common bile duct stones after ERCPXu Han, Mujie Ye, Ye Tian, et al.
Oncology Reports|July 28, 2021
[Corrigendum] Linc01105 acts as an oncogene in the development of neuroblastomaMujie Ye, Jing Ma, Baihui Liu, et al.
Oncology Reports|September 17, 2019
Linc01105 acts as an oncogene in the development of neuroblastomaMujie Ye, Jing Ma, Baihui Liu, et al.
Cancer Cell International|April 15, 2025
Carbonyl reductase 4 suppresses colorectal cancer progression through the DNMT3B/CBR4/FASN/mTOR axisJingjing Zhang, Tiaotiao Chen, Wencheng Wu, et al.
International Journal of Biological Sciences|April 17, 2023
Novel insights into the interplay between m6A modification and programmed cell death in cancerJinhao Chen, Mujie Ye, Jianan Bai, et al.
Pancreas|June 23, 2025
Long Non-Coding RNA n336928 Facilitates the Progression of Pancreatic Neuroendocrine Neoplasms via NF-κB Pathway Mediated by EZH2Mujie Ye, Ping Yu, Yi Ding, et al.
Oncology Letters|August 11, 2020
Determination of long non-coding RNAs associated with EZH2 in neuroblastoma by RIP-seq, RNA-seq and ChIP-seqMujie Ye, Lulu Xie, Jingjing Zhang, et al.
Journal of Cancer|February 3, 2025
Characteristics and function of the gut microbiota in patients with rectal neuroendocrine tumorsYue Gao, Hongxia Zheng, Mujie Ye, et al.
Cancer Gene Therapy|March 8, 2024
Identification of EGR4 as a prospective target for inhibiting tumor cell proliferation and a novel biomarker in colorectal cancerBangting Wang, Shijie Zhang, Haiyang Wang, et al.
Translational Cancer Research|September 15, 2025
Enhanced antitumor efficacy of sorafenib and everolimus combination in pancreatic neuroendocrine neoplasms through mTOR inhibitionHongxia Zheng, Yue Gao, Mujie Ye, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
BMC Gastroenterology|June 11, 2026
Machine learning models to predict the recurrence of common bile duct stones after ERCPXu Han, Mujie Ye, Ye Tian, et al.
Oncology Reports|July 28, 2021
[Corrigendum] Linc01105 acts as an oncogene in the development of neuroblastomaMujie Ye, Jing Ma, Baihui Liu, et al.
Oncology Reports|September 17, 2019
Linc01105 acts as an oncogene in the development of neuroblastomaMujie Ye, Jing Ma, Baihui Liu, et al.
Cancer Cell International|April 15, 2025
Carbonyl reductase 4 suppresses colorectal cancer progression through the DNMT3B/CBR4/FASN/mTOR axisJingjing Zhang, Tiaotiao Chen, Wencheng Wu, et al.
International Journal of Biological Sciences|April 17, 2023
Novel insights into the interplay between m6A modification and programmed cell death in cancerJinhao Chen, Mujie Ye, Jianan Bai, et al.
Pancreas|June 23, 2025
Long Non-Coding RNA n336928 Facilitates the Progression of Pancreatic Neuroendocrine Neoplasms via NF-κB Pathway Mediated by EZH2Mujie Ye, Ping Yu, Yi Ding, et al.
Oncology Letters|August 11, 2020
Determination of long non-coding RNAs associated with EZH2 in neuroblastoma by RIP-seq, RNA-seq and ChIP-seqMujie Ye, Lulu Xie, Jingjing Zhang, et al.
Journal of Cancer|February 3, 2025
Characteristics and function of the gut microbiota in patients with rectal neuroendocrine tumorsYue Gao, Hongxia Zheng, Mujie Ye, et al.
Cancer Gene Therapy|March 8, 2024
Identification of EGR4 as a prospective target for inhibiting tumor cell proliferation and a novel biomarker in colorectal cancerBangting Wang, Shijie Zhang, Haiyang Wang, et al.
Translational Cancer Research|September 15, 2025
Enhanced antitumor efficacy of sorafenib and everolimus combination in pancreatic neuroendocrine neoplasms through mTOR inhibitionHongxia Zheng, Yue Gao, Mujie Ye, et al.
Pageof 6